USA Cell Therapy Manufacturing Market Highlights Lonza Group as Global Market Reaches USD 23.2 Billion by 2036 at 14.1% CAGR | Future Market Insights

Positive

AI Analysis

Summary

Future Market Insights projects the global cell therapy manufacturing market will reach USD 23.2 billion by 2036, growing at a 14.1% CAGR, with Lonza Group highlighted as a key market participant in the USA.

Financial Highlights

Revenue

USD 23.2 Billion

Guidance

14.1% CAGR by 2036

Importance:2/10

Sentiment:

0.30

cell therapymanufacturingmarket analysisregenerative medicinemarket projection

Related Companies

$LONN.SW

Read the original article

Published by PR Newswire Pharma on July 27, 2026 4:10 PM

Read Original